Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Spectral enrolled 13+ patients per month!

<< Previous

Bullboard Posts

Next >>

Post by hmmmmmmmmon Apr 14, 2023 2:40am

630 Views

Post# 35394572

Spectral enrolled 13+ patients per month!

As Seto and Kellum compared the current Tigris enrollment to that of Euphrates- I thought I'd take a look back. Here are some of Spectral's enrollment announcements from 2013 to 2016. (links below)

On July 13 2013 Euphrates had 156 patients enrolled. By April 11 of 2014 it was 271.

So in 9 months Dr Walker and Co. enrolled 115 patients- almost 13 per month

By Jan 25 2015 they had 400 patients enrolled.

So in that 9.5 months 129 patients were added. Just over 13 1/2 per month.

On June 20 2016 they announced the trial had completed enrollment. Not clear if that was the date of the last patient- but if it was the final 46 patients took them18 months - or only 2.5 per month.

So at one time the Spectral enrolled 13+ patients per month.

Most shareholders would see that as a pretty amazing difference from the almost 2 per month we've seen over 3 years with Tigris.

Seto and Kellum's version of "doing better" seems to be based on the idea that Euphrates used more sites.

So why didn't they start Tigris with more sites! It's some pretty easy math. Spectral had their"known" average per month per site. Maybe they could have figured out that if they had only 1/3 as many sites it would take 3 times as long...

And we wonder why we're in the .20s

2013

https://www.newswire.ca/news-releases/spectral-provides-update-on-its-euphrates-trial-512764141.html

2014

https://www.obio.ca/obio-backup/obio1/2014/04/spectral-updates-status-of-euphrates-trial

2015

https://s27.q4cdn.com/906368049/files/January-25-2015_T.EDT_Marckx.pdf

2016

https://sports.yahoo.com/news/spectral-medical-announces-completion-enrolment-120000396.html

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season